Azerbaijan vs Mauritania: Estimated antiretroviral therapy coverage among people living with HIV
Azerbaijan
81.0%
in 2025
Mauritania
81.0%
in 2025
Azerbaijan rank
49th
Mauritania rank
49th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Azerbaijan
- Mauritania
How they compare
Azerbaijan currently reports 81.0% against 81.0% in Mauritania, a difference of 0.0%.
Across all 25 years both countries report, Mauritania has been ahead every year.
Azerbaijan ranks 49th and Mauritania ranks 49th of 143 countries.
Mauritania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.6% | 7.4% | 6.9% | Mauritania |
| 2010s | 20.9% | 41.0% | 20.1% | Mauritania |
| 2020s | 62.3% | 70.3% | 8.0% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Azerbaijan or Mauritania?
- Azerbaijan, at 81.0% against 81.0% in Mauritania as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Azerbaijan and Mauritania?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Mauritania?
- 25 years are reported by both, from 2000 to 2025.
- How do Azerbaijan and Mauritania rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Azerbaijan ranks 49th and Mauritania ranks 49th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.